DR. RAVIKIRAN A BARIGALA M.D.
Prescription History 1801805437
Internal Medicine in Chicago, IL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RAVIKIRAN A BARIGALA M.D., an active Internal Medicine specialist practicing in Chicago, IL. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 161 documented patient claims. Among these therapy options, the most frequently utilized medication is Doxycycline Hyclate, which accounts for 40 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IL PrescribersVs. IL Avg |
|---|---|---|---|
| Doxycycline Hyclate | 40 | $15.70 | ▲ More than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 40 Medicare prescriptions for Doxycycline Hyclate, about 1.3 times the volume of the typical Illinois prescriber of this medication (30.2). Medicare paid an average of $15.70 per fill, versus $12.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44.5 30-Day Fills standardized to 30-day supplies 1,079 Days of Medication total across all patients in 2024 | |||
| Daptomycin | 24 | $256.31▼ below IL avg | ≈ Typical |
About Daptomycin: This medication is an antibiotic used to treat serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. Daptomycin is not recommended for use in children younger than 12 months due to possible risk of serious side effects. A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. In 2024, this provider wrote 24 Medicare prescriptions for Daptomycin, about the same volume as the typical Illinois prescriber of this medication (26.4). Medicare paid an average of $256.31 per fill, versus $746.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 24 30-Day Fills standardized to 30-day supplies 157 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $13.63 | ≈ Typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 23 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 89% of the volume of the typical Illinois prescriber of this medication (25.9). Medicare paid an average of $13.63 per fill, versus $8.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 277 Days of Medication total across all patients in 2024 | |||
| Levofloxacin | 16 | $2.71▼ below IL avg | ▼ Less than typical |
About Levofloxacin: Levofloxacin is used to treat a variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2024, this provider wrote 16 Medicare prescriptions for Levofloxacin, about 66% of the volume of the typical Illinois prescriber of this medication (24.4). Medicare paid an average of $2.71 per fill, versus $5.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 16.5 30-Day Fills standardized to 30-day supplies 246 Days of Medication total across all patients in 2024 | |||
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $2,436.54▼ below IL avg | ▼ Less than typical |
About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 12 Medicare prescriptions for Descovy, about a third of the volume of the typical Illinois prescriber of this medication (30.2). Medicare paid an average of $2,436.54 per fill, versus $2,444.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 12 | $107.12▼ below IL avg | ▼ Less than typical |
About Piperacillin-Tazobactam: Piperacillin/tazobactam is used to treat a wide variety of bacterial infections. Show more ▾ It is a penicillin antibiotic. It works by stopping the growth of bacteria. An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS. In 2024, this provider wrote 12 Medicare prescriptions for Piperacillin-Tazobactam, about 60% of the volume of the typical Illinois prescriber of this medication (19.9). Medicare paid an average of $107.12 per fill, versus $176.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 12 30-Day Fills standardized to 30-day supplies 67 Days of Medication total across all patients in 2024 | |||
| Vancomycin Hcl | 12 | $123.02 | ▼ Less than typical |
About Vancomycin Hcl: Vancomycin is used to treat a certain intestinal condition (colitis) that may rarely happen after treatment with antibiotics. Show more ▾ This condition causes diarrhea and stomach/abdominal discomfort or pain. When vancomycin is taken by mouth, it stays in the intestines to stop the growth of bacteria that cause these symptoms. This antibiotic treats only bacterial infection in the intestines. It will not work for bacterial infections in any other part of the body or for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. In 2024, this provider wrote 12 Medicare prescriptions for Vancomycin Hcl, about a third of the volume of the typical Illinois prescriber of this medication (29.8). Medicare paid an average of $123.02 per fill, versus $120.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 111 Days of Medication total across all patients in 2024 | |||
| Cefdinir | 11 | $8.41▼ below IL avg | ▼ Less than typical |
About Cefdinir: Cefdinir is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin. In 2024, this provider wrote 11 Medicare prescriptions for Cefdinir, about half the volume of the typical Illinois prescriber of this medication (25.7). Medicare paid an average of $8.41 per fill, versus $15.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 11 30-Day Fills standardized to 30-day supplies 63 Days of Medication total across all patients in 2024 | |||
| ErtapenemErtapenem Sodium | 11 | $352.73▼ below IL avg | ▼ Less than typical |
About Ertapenem: Ertapenem is used to prevent and treat a wide variety of bacterial infections. Show more ▾ This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria. A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. In 2024, this provider wrote 11 Medicare prescriptions for Ertapenem, about half the volume of the typical Illinois prescriber of this medication (23.5). Medicare paid an average of $352.73 per fill, versus $379.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 11 30-Day Fills standardized to 30-day supplies 71 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. RAVIKIRAN A BARIGALA M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Chicago, IL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
